Luvulis Corp

S-1/A amended

Price $0.02 · 4,500,000 shares · Gross proceeds $101,250

Luvulis Corp's S-1/A filing details a self-underwritten, direct offering of 4.5 million shares at $0.0225 per share, with gross proceeds of $101,250. The company, a development-stage entity with no revenue, relies on this offering to fund operations, as it has a net loss of $1,640 and $680 in cash as of January 2026. The sole officer and director, Jakub Marcin Dzierzynski, will handle sales without commissions, and the offering may terminate early if all shares are sold or the board decides. The company faces risks including lack of revenue, dependence on funding, and no public trading market.

S-1 filed

Price $0.02 · 4,500,000 shares · Gross proceeds $101,250

Luvulis Corporation, a development-stage company incorporated in Wyoming, is conducting an initial public offering (IPO) of 4,500,000 shares of common stock at $0.0225 per share. The offering is self-underwritten by CEO Jakub Marcin Dzierzynski, with no minimum purchase requirement. The company has limited operating history, audited financial statements showing a net loss of $1,640, and a going concern uncertainty. Proceeds will fund operations, but there is no public market for shares, and the offering involves high risk of loss.